PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18279543-4	2008	We discuss the estrogenic and anti-estrogenic effects of early SERMs, such as clomiphene citrate, used for treatment of ovulation induction, and the triphenylethylene, tamoxifen, which has ER antagonist activity in the breast, and is used for prevention and treatment of ER-positive breast cancer.	Clomiphene	78-96	estrogen receptor 1	Homo sapiens	64-66	
34540296-3	2021	Clomiphene citrate is a selective estrogen receptor modulator, approved for treating infertility in females, but is being used as an off-label therapy in treating male hypogonadism.	Clomiphene	0-18	estrogen receptor 1	Homo sapiens	34-51	
12004198-3	2002	The estrogen receptor ligands tamoxifen, nafoxidine and clomiphene were identified as agents which affect mitochondrial membrane potential in a cyclosporin A-like manner.	Clomiphene	56-66	estrogen receptor 1	Homo sapiens	4-21	
34278201-1	2021	Background: Clomiphene citrate is an estrogen receptor ligand with mixed agonistic-antagonistic properties used for the treatment of female and male infertility.	Clomiphene	12-30	estrogen receptor 1	Homo sapiens	37-54	
6408114-0	1983	Antitumor activity of clomiphene analogs in vitro: relationship to affinity for the estrogen receptor and another high affinity antiestrogen-binding site.	Clomiphene	22-32	estrogen receptor 1	Homo sapiens	84-101	
3569554-0	1987	Estrogen receptor binding material in blood of patients after clomiphene citrate administration: determination by a radioreceptor assay.	Clomiphene	62-80	estrogen receptor 1	Homo sapiens	0-17	
27033325-0	2016	Clomiphene citrate down-regulates estrogen receptor-alpha through the ubiquitin-proteasome pathway in a human endometrial cancer cell line.	Clomiphene	0-18	estrogen receptor 1	Homo sapiens	34-57	
32502769-11	2020	Furthermore, by employing open-source, biological data we identified a common gene (Estrogen Receptor 1, ESR1) between genetic targets of clomiphene treatment and POR which could explain the benefits of clomiphene in this group of patients.	Clomiphene	138-148	estrogen receptor 1	Homo sapiens	84-103	
32502769-11	2020	Furthermore, by employing open-source, biological data we identified a common gene (Estrogen Receptor 1, ESR1) between genetic targets of clomiphene treatment and POR which could explain the benefits of clomiphene in this group of patients.	Clomiphene	138-148	estrogen receptor 1	Homo sapiens	105-109	
32502769-11	2020	Furthermore, by employing open-source, biological data we identified a common gene (Estrogen Receptor 1, ESR1) between genetic targets of clomiphene treatment and POR which could explain the benefits of clomiphene in this group of patients.	Clomiphene	203-213	estrogen receptor 1	Homo sapiens	84-103	
32502769-11	2020	Furthermore, by employing open-source, biological data we identified a common gene (Estrogen Receptor 1, ESR1) between genetic targets of clomiphene treatment and POR which could explain the benefits of clomiphene in this group of patients.	Clomiphene	203-213	estrogen receptor 1	Homo sapiens	105-109	
27033325-1	2016	We examined how clomiphene citrate (CC) reduces estrogen receptor-alpha (ERalpha) in a human endometrial cancer cell line.	Clomiphene	16-34	estrogen receptor 1	Homo sapiens	48-71	
27033325-1	2016	We examined how clomiphene citrate (CC) reduces estrogen receptor-alpha (ERalpha) in a human endometrial cancer cell line.	Clomiphene	16-34	estrogen receptor 1	Homo sapiens	73-80	
26692070-6	2015	In addition, pretreatment with estrogen receptor (ER) antagonists such as clomiphene, tamoxifen, or fulvestrant, significantly reversed the proliferative effect of each photoinitiator.	Clomiphene	74-84	estrogen receptor 1	Homo sapiens	31-48	
26692070-6	2015	In addition, pretreatment with estrogen receptor (ER) antagonists such as clomiphene, tamoxifen, or fulvestrant, significantly reversed the proliferative effect of each photoinitiator.	Clomiphene	74-84	estrogen receptor 1	Homo sapiens	50-52